No Data
No Data
<Today's main economic Indicators and schedule> Elecom will have an IPO, April consumer price index in the Tokyo metropolitan area, ETC.
【Domestic】・ 8:30 April Consumer Prices in the Tokyo Metropolitan Area ・ 14:00 March National Department Stores revenue ・ Earnings Reports = Keyence <6861.T>, Shin-Etsu Chemical <4063.T>, Daiichi Sankyo <4568.T>, Denso <6902.T>, Advantest <6857.T>, Astellas Pharma <4503.T>, Nomura <8604.T> ・ IPO (New Listing) = Elevator Communications (Eureka) <353A.SP> 【Overseas】 (Time is Japan time) ・ 23:00
Mitsubishi Research Institute, Daiichi Sankyo, Hitachi Construction, Keyence (on the 25th).
※The above Calendar is merely a schedule and may be subject to change due to the company's circumstances.---------------------------------------April 25 (Friday) <1381> Axes <1944> Kinden <1972> Sanko Gold <2208> Bourbon <2212> Yamazaki Bread <2216> Kanro <2481> Town News <3003> Hulic <3116>
Nomura HD, Chugai Pharmaceutical, Fujitsu, Canon Inc-Spons Adr (24th)
※The above Calendar is just a plan and may change due to the company's circumstances. --------------------------------------- April 24 (Thursday) <2211> Fujika <2664> Kawachi Drug <2737> Tomen Deba <3231> Nomura Real Estate HD <3593> Hogi Medi <3891> Advanced Paper <4307> NRI <4519> Chugai Pharmaceutical <4765>
Daiichi Sankyo (ADR) (DSNKY.US) will release its Earnings Reports on April 25.
$Daiichi Sankyo (ADR) (DSNKY.US)$ will release its Earnings Reports on April 25, and investors are advised to pay attention. How was the performance previously? $Daiichi Sankyo (ADR) (DSNKY.US)$ reported a revenue of 484.84 billion yen and a Net income of 61.928 billion yen in Q3 2025, with an EPS of 32.79 yen. For Q4 2024, the revenue was 428.419 billion yen, with a Net income of 36.914 billion yen and an EPS of 19.37 yen. The accounting standards used for the above data are NonUS_GAAP. Futubull reminder: 1. Listed on Hong Kong stocks and U.S. stocks.
AstraZeneca- Daiichi Sankyo's Multi-Billion Dollar Cancer Drug Shows Superior Efficacy Across Broad HER2 Positive Metastatic Breast Cancer Patients
AstraZeneca Says Breast Cancer Combination Therapy Shows Improvement in Progression-Free Survival
72423057 : I would like to ask the person who studies the stock price chart, what is the stock price determination chart? Or is it the future trend of the chart's final stock price?
Buy n Die Together❤ 72423057 : Chart is just a references, history or an information for you to guess what the price or trend going to form in the future. And is no guarentee that even you study the chart you will know the future. And if eg 1000 people see the same chart and almost 90% guess the same things maybe it will be chart leading us to play in the same way to had that same outcome.![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
Buy n Die Together❤ : Another to ask yourself is,, You play the game? Or the game play you.![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
wahlao 72423057 : Its human emotions determine stock price, price determine chart. See chart to see human emotions, but humans could be logical so u can't be sure 100%. It's the meaning of life. Deep.
fearless Puppy_9024 72423057 : Stock prices determine charts through recorded trading activity. However, charts can influence market behavior indirectly when traders use them to predict trends. External variables like institutional trades, company news(e.g. earning reports, mergers, acquisitions, product launches or management change) and micro-economic factors(e.g. interest rate, political events, global market conditions) can also override typical chart-based predictions by introducing sudden volatility or trends.
View more comments...